ConductScience.org, home

Paper309487

Enhancement of T cell cytotoxic responses by purified human fibroblast interferon.

Zarling JM and 5 others. J Immunol, 1978. Cited by 88 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Enhancement of T cell cytotoxic responses by purified human fibroblast interferon. Papers, record 309487. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/309487

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Enhancement of T cell cytotoxic responses by purified human fibroblast interferon.
PubMed
Journal
J Immunol
PubMed
Year
1978
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
88
iCite
Relative citation ratio, by iCite
2.63
iCite
Revised in PubMed
2006-11-15
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zarling JMJ M
2Sosman JJ
3Eskra LL
4Borden ECE C
5Horoszewicz JSJ S
6Carter WAW A

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cytotoxicity, ImmunologicMajor topic
InterferonsMajor topic
T-LymphocytesMajor topic
Fibroblasts
Humans
Isoantigens

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.

PMIDTitleJournalYearIn PapersSource
30679806Interferons α and β in cancer: therapeutic opportunities from new insights.Nat Rev Drug Discov2019https://conductscience.org/library/papers/30679806PubMed
8984676Mechanisms of action of interferon-beta in multiple sclerosis.Springer Semin Immunopathol1996https://conductscience.org/library/papers/8984676PubMed
6676984Biosynthetic human interferon treatment of herpetic keratitis.Trans Am Ophthalmol Soc1983https://conductscience.org/library/papers/6676984PubMed
6403469Potentiation of lymphocyte natural killing by mixtures of alpha or beta interferon with recombinant gamma interferon.Infect Immun1983https://conductscience.org/library/papers/6403469PubMed
6308051Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.J Clin Invest1983https://conductscience.org/library/papers/6308051PubMed
6176663Interferon inhibits the generation of allospecific suppressor T lymphocytes.J Exp Med1982https://conductscience.org/library/papers/6176663PubMed
6174540Augmentation of natural and antibody-dependent cell-mediated cytotoxicity by pure human leukocyte interferon.J Clin Immunol1981https://conductscience.org/library/papers/6174540PubMed
6167513Antiviral agents: an update--Part 2.Indian J Pediatr1980https://conductscience.org/library/papers/6167513PubMed
6165341Differences between human alpha (leukocyte) and beta (fibroblast) interferons.Arch Virol1981https://conductscience.org/library/papers/6165341PubMed
6155926Enhancement of human natural cell-mediated cytotoxicity by interferon.Br J Cancer1980https://conductscience.org/library/papers/6155926PubMed
3416325Comparative studies between in vitro and in vivo effects of human beta-interferon on natural killer activity and its relevance to immunochemotherapy.Cancer Immunol Immunother1988https://conductscience.org/library/papers/3416325PubMed
3127093Role of IL-2 and interferon in the generation of natural cytotoxic activity in influenza virus-stimulated PBL cultures: analysis with the use of prednisolone.Clin Exp Immunol1988https://conductscience.org/library/papers/3127093PubMed
2484953Effects of interferons on human B-cell differentiation in vitro.Korean J Intern Med1987https://conductscience.org/library/papers/2484953PubMed
2440628Effects of interferons and interleukin 2 on natural killing of cytomegalovirus-infected fibroblasts.Clin Exp Immunol1987https://conductscience.org/library/papers/2440628PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
IFNB13456PubTator's text mininghttps://conductscience.org/library/genes/3456

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/309487

GET https://conductscience.org/api/papers/v1/309487/authors